Drug discovery is lengthy process which costs 2.6B per approved drug on average. The cost is so high because finding a small molecule that binds to a particular target is a perilous highly uncertain process that can’t be completed in a decade in many of the cases. And even when a molecule is found it might not be doing its job very well and might very likely fail in later stages of trials. Our goal is to find much better drug candidate molecules and do it very fast.